Insider: Patel Anish CHIEF OPERATING OFFICER - Enliven Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,440 | 283,308 | 284,748 |
| Value | $27,244.80 | $5,360,187.36 | $5,387,432.16 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/08/2025 | DDS | 6,667 | Indirect | COM | $20.24 | $134,957.41 | 283,308 |
| 08/07/2025 | DDS | 6,262 | Indirect | COM | $18.20 | $113,948.99 | 290,380 |
| 08/07/2025 | DDS | 405 | Indirect | COM | $18.93 | $7,666.53 | 289,975 |
| 07/07/2025 | DDS | 6,362 | Indirect | COM | $19.75 | $125,638.68 | 296,947 |
| 07/07/2025 | DDS | 305 | Indirect | COM | $20.69 | $6,311.91 | 296,642 |
| 06/09/2025 | DDS | 60 | Indirect | COM | $21.16 | $1,269.60 | 303,309 |
| 06/09/2025 | DDS | 6,607 | Indirect | COM | $20.33 | $134,304.45 | 303,369 |
| 05/07/2025 | DDS | 6,173 | Indirect | COM | $18.30 | $112,946.76 | 310,470 |
| 05/07/2025 | DDS | 390 | Indirect | COM | $19.40 | $7,565.42 | 310,080 |
| 05/07/2025 | DDS | 104 | Indirect | COM | $19.87 | $2,066.68 | 309,976 |
| 04/07/2025 | DDS | 2,763 | Indirect | COM | $18.29 | $50,526.98 | 316,791 |
| 04/07/2025 | DDS | 3,756 | Indirect | COM | $17.81 | $66,889.48 | 319,554 |
| 04/07/2025 | DDS | 148 | Indirect | COM | $19.27 | $2,852.27 | 316,643 |
| 03/07/2025 | DDS | 6,667 | Indirect | COM | $21.44 | $142,936.48 | 323,310 |
| 02/07/2025 | DDS | 6,667 | Indirect | COM | $21.93 | $146,205.98 | 329,977 |
| 01/07/2025 | DDS | 20,260 | Direct | COM | $24.15 | $489,329.65 | 1,440 |
| 01/07/2025 | DDS | 1,440 | Direct | COM | $24.56 | $35,367.84 | 0 |
| 01/07/2025 | DDS | 90 | Indirect | COM | $24.60 | $2,214.07 | 336,644 |
| 01/07/2025 | DDS | 6,577 | Indirect | COM | $24.17 | $158,956.88 | 336,734 |
| 10/18/2024 | DDS | 716 | Indirect | COM | $30.00 | $21,482.51 | 343,311 |
| 06/06/2024 | DDS | 1,133 | Direct | COM | $20.06 | $22,722.43 | 0 |
| 05/14/2024 | DDS | 1,107 | Direct | COM | $25.00 | $27,675.00 | 0 |
| 05/09/2024 | DDS | 260 | Direct | COM | $25.06 | $6,515.50 | 0 |
| 05/06/2024 | DDS | 4,875 | Direct | COM | $22.72 | $110,769.26 | 0 |
| 04/11/2024 | DDS | 17,500 | Direct | COM | $25.03 | $438,098.50 | 0 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research